CPHI vs PPL · rev $4.1M vs P/E 22, rev $8.46B
China Pharma Holdings Inc (CPHI) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
CPHI currently screens at market cap $29.0M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the CPHI and PPL stock pages for the full models.
Not investment advice.